Biomaterials boosted as investors return / This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says / Leerink upgrades this beaten-down biotech stock, says investors should buy the dip / Buy this biotech stock that can rally more than 65%, Goldman says / This little-known biotech stock is a buy that's primed to double in price, Goldman says / This biotech stock is an 'oncology powerhouse' with 40% upside, says Truist Securities / These innovative biotech stocks have a good chance of breaking out in 2025 / Wells Fargo sees this biotech stock rallying 75% in its bull case / JPMorgan's top biotech stock picks for 2025 as sector looks for a comeback year / These 9 biotech stocks have doubled this year and are set to double again, analysts say